ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.77363
1.31%
Brent Oil
78.305
-1.16%
Bitcoin
104,257.80
2.18%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF) Cotización

Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF)

USOTC
0.12
0.00
(0.00%)
Cerrado 21 Enero 3:00PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
0.12
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.000001 Rango de 52 semanas 0.35
Capitalización de Mercado [m]
14.445M
Precio Anterior
0.12
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
28,467
Acciones en circulación
120,377,529
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.52
Beneficio por acción (BPA)
-0.05
turnover
35.43M
Beneficio neto
-5.74M

Acerca de Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.parnell.com
Sede
Sydney, New South Wales, Aus
Fundado
-
Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was US$0.12. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.35.

Parnell Pharmaceuticals (CE) currently has 120,377,529 shares in issue. The market capitalisation of Parnell Pharmaceuticals (CE) is US$14.45 million. Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of -2.52.

PARNF Últimas noticias

Más noticias

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

19 Diciembre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

09 Diciembre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

22 Noviembre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

02 Noviembre 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

27 Octubre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

04 Agosto 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

26 Julio 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

31 Mayo 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock

OVERLAND PARK, Kan., May 12, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

12 Mayo 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update

Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings...

22 Abril 2016
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.120.120.125000.12CS
40.03846.34146341460.0820.180.082195800.1423284CS
120.071400.050.350.05284670.08767723CS
260.11991199000.00010.351.0E-6206910.08616385CS
520.119999119999001.0E-60.351.0E-6148680.08393423CS
1560.11991199000.00010.351.0E-6133180.02880215CS
2600.029933.18534961150.09010.891.0E-6124140.21483978CS

PARNF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Parnell Pharmaceuticals (CE)?
El precio actual de las acciones de Parnell Pharmaceuticals (CE) es US$ 0.12
¿Cuántas acciones de Parnell Pharmaceuticals (CE) están en circulación?
Parnell Pharmaceuticals (CE) tiene 120,377,529 acciones en circulación
¿Cuál es la capitalización de mercado de Parnell Pharmaceuticals (CE)?
La capitalización de mercado de Parnell Pharmaceuticals (CE) es USD 14.45M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Parnell Pharmaceuticals (CE)?
Parnell Pharmaceuticals (CE) ha negociado en un rango de US$ 0.000001 a US$ 0.35 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Parnell Pharmaceuticals (CE)?
El ratio precio/beneficio de Parnell Pharmaceuticals (CE) es -2.52
¿Cuál es el ratio de efectivo a ventas de Parnell Pharmaceuticals (CE)?
El ratio de efectivo a ventas de Parnell Pharmaceuticals (CE) es 0.41
¿Cuál es la moneda de reporte de Parnell Pharmaceuticals (CE)?
Parnell Pharmaceuticals (CE) presenta sus resultados financieros en AUD
¿Cuál es el último ingresos anual de Parnell Pharmaceuticals (CE)?
El último ingresos anual de Parnell Pharmaceuticals (CE) es AUD 35.43M
¿Cuál es el último beneficio anual de Parnell Pharmaceuticals (CE)?
El último beneficio anual de Parnell Pharmaceuticals (CE) es AUD -5.74M
¿Cuál es la dirección registrada de Parnell Pharmaceuticals (CE)?
La dirección registrada de Parnell Pharmaceuticals (CE) es UNIT 4 CENTURY ESTATE, 476 GARDENERS ROAD, ALEXANDRIA, SYDNEY, NEW SOUTH WALES, 2015
¿Cuál es la dirección del sitio web de Parnell Pharmaceuticals (CE)?
La dirección del sitio web de Parnell Pharmaceuticals (CE) es www.parnell.com
¿En qué sector industrial opera Parnell Pharmaceuticals (CE)?
Parnell Pharmaceuticals (CE) opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AABVFAberdeen International Inc (PK)
US$ 0.0242
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.03035
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0242
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.03035
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0242
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.03035
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0

Discusión

Ver feed completo
don estaban don estaban 5 minutos hace
I used to back in the day seems like a waste of my time the last year
MVNT
rolvram rolvram 5 minutos hace
Investing.com -- Tesla continues to be Piper Sandler's "#1 buy-and-hold idea," as the firm raised its price target for the stock from $315 to $500.
TSLA
maryj55555 maryj55555 5 minutos hace
Let's make penny stocks great again. Let her rip it wasn't to long ago she ran to .0012 
TKMO
gt1217 gt1217 5 minutos hace
Next needs to be the case going away as well!!!!!
BTCUSD
RIGATONI RIGATONI 6 minutos hace
$5.80 and looking for that $6.00 break/hold ~Rig
JohnnyMakeBucks JohnnyMakeBucks 6 minutos hace
Those aren’t with VStock Transfer. Contrary to message board opinion companies don’t have control of when data gets reported once you’re part of the otcmarkets TA share program.
IDVV
JohnnyMakeBucks JohnnyMakeBucks 6 minutos hace
Those aren’t with VStock Transfer. Contrary to message board opinion companies don’t have control of when data gets reported once you’re part of the otcmarkets TA share program.
IDVV
Methinks Methinks 6 minutos hace
https://www.pentestpartners.com/security-blog/how-to-secure-body-worn-cameras-and-protect-footage-from-cyber-threats/
"Store cryptographic keys in a TPM or TrustZone. " Wave must be used, here.
georgie18 georgie18 7 minutos hace
TTOO...286...🥳...on this Oversold Bottom...

georgie18

Member Level
Re: None

Saturday, January 18, 2025 12:42:24 PM

Post#
671765
of 671806
TTOO...26...🥳... https://schrts.co/wkTpqqTF ...Bullish
TTOO
weedtrader420 weedtrader420 7 minutos hace
TSLA TLSS $1500 TARGET
TLSS TSLA
georgie18 georgie18 7 minutos hace
TTOO...286...🥳...on this Oversold Bottom...

georgie18

Member Level
Re: None

Saturday, January 18, 2025 12:42:24 PM

Post#
671765
of 671806
TTOO...26...🥳... https://schrts.co/wkTpqqTF ...Bullish
TTOO
georgie18 georgie18 7 minutos hace
TTOO...286...🥳...on this Oversold Bottom...

georgie18

Member Level
Re: None

Saturday, January 18, 2025 12:42:24 PM

Post#
671765
of 671806
TTOO...26...🥳... https://schrts.co/wkTpqqTF ...Bullish
TTOO
rolvram rolvram 8 minutos hace
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
______________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): Januar
DGX MGX NVDA
AlwaysOptimistic AlwaysOptimistic 8 minutos hace
IonQ Awarded Prestigious Recognitions by Forbes, Investor’s Business Daily and Built In

https://finance.yahoo.com/news/ionq-awarded-prestigious-recognitions-forbes-120500569.html
IONQ
georgie18 georgie18 9 minutos hace
Thanks Rig...🥳
Nogobeaver Nogobeaver 9 minutos hace
Good morning robo posting crew! I see you are at it bright and early. Keep at it, its very effective..
SGTM
Dcab Dcab 9 minutos hace
Halting these stocks is a confiscation of wealth, just another form of slavery 101 by the gov't. Keep the population down and in place that is the goal. Create
obedient workers and then take all their money in taxes and put it in the pockets of the politicians. Good scam if you can sell i
TWOH
Methinks Methinks 9 minutos hace
https://en.interfax.com.ua/news/general/1041920.html
Stop it before it can damage the systems - with Wave.
RIGATONI RIGATONI 10 minutos hace
.92s nice ~Rig
Z06 MAN Z06 MAN 11 minutos hace
No news this week either?… Not liking the silent treatment again… I guess my patience has worn thin.

No news this week, from previous Pr’s, there seems to be some great material news Kim could be disclosing to shareholders. Another week into 2025 and No production news…. Go Figure….
KBLB
LVerstee LVerstee 11 minutos hace
A plan is simply a plan, not a guarantee. Continually stating that he is planning to without actually following through on any of those plans is nothing else but a way to avoid responsibility.
ITUP
Methinks Methinks 11 minutos hace
https://www.csoonline.com/article/3805122/healthcare-most-vulnerable-to-cyber-threats-eu-launches-action-plan.html
I've got an action plan for them! Wave.
CelestialOgre14 CelestialOgre14 11 minutos hace
600% in 10 years
ELTP
Jake731 Jake731 12 minutos hace
Good morning all..




TPTW……!!!!!!!
TPTW
budfoxfun budfoxfun 13 minutos hace
CEO of The Sustainable Green Team https://thesustainablegreenteam.com/sgtm-blog/f/tony-raynor-founder-and-ceo-of-the-sustainable-green-team?blogcategory=SGTM+Leadership
SGTM

Su Consulta Reciente

USOTC
PARNF
Parnell Pharmaceuticals (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados